Stock Markets Analysis & Opinion

Wednesday, Dec. 15, saw the conclusion of the most highly anticipated Fed meeting of the year as investors try to get a feel for the type of economic climate they'll be trading in the New Year.Federal...

The one big thing on everyone’s minds at the moment is Omicron and the way that it is spreading. For investors, it isn’t just the fear of getting infected or worse, hospitalized....

Neogen (NASDAQ:NEOG) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.15 per share a year ago. These...

(Tuesday Market Open) S&P Index Futures were trading 1% higher in pre-market trading as stocks looked to rebound from Monday’s selloff. Tech appeared to be set to lead as the tech-heavy...

Chevron Corporation (NYSE:CVX)’s CVX affiliate Chevron Suriname Exploration (CSEL) recently agreed to sell its 20% holding in Block 5 off the coast of Suriname to a unit of Royal Dutch Shell...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 22nd:ArcBest (NASDAQ:ARCB) Corporation ARCB: This provider of freight transportation...

The S&P 500 tumbled 1.1% on Monday and gained 1.8% on Tuesday. So much for all the fear-mongering and panicked selling. But this outcome was largely expected. As I wrote after Monday's...

The game between the S&P 500 and the VIX is getting pretty stupid. The VIX gapped higher on Monday, reaching 27, and Tuesday it went back to 21, and you keep having these Vanna squeezes. There was...

As the year nears its end, we have a lot of ideas to keep watch of. Tuesday’s price action could be the late Santa rally people were hoping for. Though it's better late than never, we...

It has been about a month since the last earnings report for Central Garden (CENT). Shares have lost about 1.7% in that time frame, underperforming the S&P 500.Will the recent negative trend...

Eli Lilly & Company LLY announced data from the third pivotal phase III study — ADhere — evaluating its investigational IL-13 inhibitor, lebrikizumab, in combination with topical...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Investors in Sea Limited SE need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $100.00 Put had some of the highest implied...

The most significant risk to stocks is not the Fed.Over the next few months, you will see a lot of articles suggesting that initial rate hikes from the Fed don’t impact stocks. Such as this...